The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
251-500 Employees
2010
STANDARD Q provides various rapid test parameters with high sensitivity and specificity through quality control from raw material development to production. STANDARD F is a multi-parametric and random accessible FIA system providing accurate diagnostic results to your laboratory. STANDARD M is a Point-of-Care MDx system designed for more accurate, simpler and faster clinical decision making near-the-patient. We introduce various SD BIOSENSOR products that will be useful for conducting diagnostic tests.
+
Featured
SD BIOSENSOR | PRODUCTS
... SD BIOSENSOR | ...
51-100 Employees
2001
Universal Biosensors Inc (UBI) is a global biosensor company and a world leader in electrochemical cell technology. UBI is a USA Delaware company listed on the Australian Securities Exchange (ASX:UBI) and operates from its head office, manufacturing facility, and research laboratory in Melbourne, Victoria, Australia. These products will complement UBI’s existing Canadian blood testing laboratory Hemostasis Reference Lab (HRL). Develops hand-held portable devices incorporating state-of-the-art signal processing with rich, touchscreen-based user interfaces in products that are robust enough to withstand vigorous requirements. Our technology platform has delivered more than 10 billion diagnostic tests to patients worldwide in glucose and coagulation products. Hemostasis Reference Laboratory (HRL) is a specialized laboratory with a long history of assisting clients with study design and assay selection to help ensure the best possible outcomes.
+
Featured
Universal Biosensors Australia
... Universal Biosensors Inc (UBI) is a global biosensor company and a world leader in electrochemical cell technology. UBI’s ambition is to utilize its patented biosensor technology to develop a diverse rangeof biosensor test strips used in our hand-held portable analyzers; ...
Istanbul, Turkey
1-10 Employees
2017
Aksense consists of a group of experienced scientists and entrepreneurs innovating in the Biotech space. Aksense has developed the first portable diagnostics biosensor to identify healthcare-associated infections in minutes, enabling accurate diagnosis and treatment, saving time, money and lives. We are interested in talking to potential investors in this space. Prior to Aksense, Asiye and Mürsel worked together in hospitals, and have known each other for over 12 years. Asiye is a clinical microbiologist and has over a decade of experience with infection diagnosis in hospitals. Asiye is leading the financial process of Aksense. Mürsel is leading the technical process at Aksense. Serap is a scientist in the field of Bioengineering.
+
Featured
Portable diagnostics biosensor | Healthcare-associated infections
... Aksense is a portable diagnostics biosensor device. Quick and accurate diagnosis in minutes, doctors provide treatment quickly, saving time, money and ...
+
Featured
LATEST GENERATION PATENTED BIOSENSORS AVAILABLE TODAY !
... PAVION® the world's first ionic conductive dry polymer for next-generation biosensors ...
London, United Kingdom
11-50 Employees
2016
This provides instant personalized dose information; maximizing drug treatment efficacy and minimizing toxicity. The 'free vancomycin' level is currently estimated based on 'total vancomcyin' test results, leading to further inaccurate dosing. The process used today involves numerous inputs from various experts. In the US, 60% of vancomycin doses are administered outside the therapeutic range leading to adverse side effects & ineffective treatment. All our partnerships provide access to ZiO Health’s biosensor platform.
+
Featured
Biosensor Technology
... Proprietary pocket-sized biosensor technology, bringing laboratory testing to the point-of-care to improve patient outcomes @ ZIO ...
+
Featured
Mutation specific biosensors to accelerate drug development
... We develop a constantly expanding platform of unique kinase activity biosensors. ...
London, United Kingdom
1-10 Employees
2022
This is a low cost process without large minimum order quantities. The screen-printing process enables rapid manufacture of electrodes with great scalability.
+
Featured
Discover How We Can Upgrade Your Biosensors
... Discover How We Can Upgrade Your Biosensors ...
Oxford, United Kingdom
We are translating decades of ground-breaking research from the University of Oxford into useable tools and products for application in industry and the environment worldwide. In parallel we are developing a portable device which will enable our customers to use the biosensors on site and in remote locations, with data relayed wirelessly. Early detection of toxicity and heavy metals to avoid production loss. The first step in addressing this issue is the detection of these contaminants, which combined with our mathematical models can offer valuable insights into sources, sinks and impacts of pollution and help advise on clean-up strategies. In light of the issues facing the water industry today, we are offering a range of products and services based around whole-cell biosensor technology; sensing cells able to detect toxicity, heavy metals, antibiotics and many more pollutants with greater sensitivity than ever before. Currently we offer lab-based services for numerous industries; detecting environmental and industrial pollution, identifying degradation pinch-points, toxicity at both a cellular and genetic level, as well as data analysis and consultation for contamination remediation strategies.
+
Featured
Technology — Oxford Molecular Biosensors
... Technology — Oxford Molecular Biosensors ...
United States
1-10 Employees
2013
At AB, our mission is to provide our customers with comprehensive, high-quality solutions that improve productivity and process reliability which results in superior bio-manufacturing and life-science products. Applied Biosensors LLC (AB) was established in 2014 to transform the production of life-saving medicines. The company’s first product, InSens4™, is an in-line multi-analyte sensor that can simultaneously monitor critical process parameters such as Glucose, Lactate, Osmolality, and pH. The InSens4™ is designed for use in the biomanufacturing industry. Applied Biosensors plans to offer data analytics services based on the data generated by its sensors with a long-term vision to bringing machine learning and artificial intelligence to bioproduction, thus enabling complete automation of bioproduction facilities. At Applied Biosensors (AB), we are working to shape the future of biomanufacturing. This will provide the biopharmaceutical industry with the ability to monitor the production of therapeutic proteins in-situ and real-time.
+
Featured
Solutions | Applied Biosensors
... Solutions | Applied Biosensors ...
Nicosia, Cyprus
1-10 Employees
2018
Our mission is to develop the necessary diagnostic tools for early diagnosis and treatment of acute infections at the point of need. Prior to bialoom Stella has been a researcher and entrepreneur in the field of diagnostics. We are sorry, there are no vacancies for now, please visit us again in the future. Our solution leverages proprietary silicon plasmo-photonic biosensor technology to deliver powerful and affordable biochips embedded in a disposable cartridge. Use standard semiconductor technology (CMOS) for low-cost volume manufacturing of multi-sensor chip. Thanasis is a computer science graduate from Aristotle university of Thessaloniki. Since 2020, George is leading assay development at bialoom, seeking to combine its groundbreaking sensing platform with advanced (bio)chemical modification techniques. Since 2021 Mahmoud holds the role of Photonics Engineer at bialoom leading PIC design and numerical simulation activities.
+
Featured
BREAKTHROUGH BIOSENSOR TECHNOLOGIES
... Bialoom – Breakthrough Biosensor ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Biosensors
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 197 |
| Amount of suitable service providers | 122 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2001 |
| Youngest suiting company | 2022 |
Biosensors are analytical devices combining a biological component with a physicochemical detector to measure a chemical substance, translating its concentration into an electrical signal. This conversion happens through a bio-recognition process, where the biological element, such as enzymes, antibodies, nucleic acids, or microorganisms, interacts specifically with the target analyte. The physicochemical detector, often referred to as the transducer, then converts this biological response into a measurable electrical signal. The sensitivity and specificity of biosensors make them invaluable tools across various sectors, including healthcare, environmental monitoring, food safety, and biotechnology. In healthcare, for instance, they play a pivotal role in diagnosing diseases, monitoring glucose levels in diabetic patients, and detecting pathogens. Environmental applications include the detection of pollutants and the monitoring of water quality. In the food industry, biosensors are used to identify potential contaminants and ensure product safety. The integration of biosensors into these fields has revolutionized the approach to real-time monitoring and analysis, providing rapid, accurate, and cost-effective solutions. Their ability to deliver immediate results is particularly critical in settings where time-sensitive decisions are essential, highlighting their significant impact on both technological advancement and societal well-being.
1. High Sensitivity and Specificity
Biosensors are renowned for their exceptional sensitivity and specificity. This means they can detect the smallest concentrations of analytes, including pathogens, toxins, or other biomolecules, with great accuracy. This high level of precision is crucial in applications such as medical diagnostics, where the early detection of diseases can significantly impact treatment outcomes.
2. Real-Time Analysis
One of the standout advantages of biosensors is their ability to provide real-time monitoring and analysis. This is particularly beneficial in critical care and environmental monitoring, where immediate data can inform timely decisions. The capability to monitor changes in real-time without the need for sample processing or lengthy lab analysis is a game-changer.
3. Portability and Ease of Use
Biosensors are often compact and user-friendly, making them accessible to non-experts. This portability allows for on-site testing in a variety of settings, from fieldwork in environmental studies to point-of-care diagnostics in healthcare. The ease of use and minimal training requirements further enhance their applicability across disciplines.
4. Cost-Effectiveness
Compared to traditional analytical techniques, biosensors can be more cost-effective, especially in the long run. Their low operating costs, coupled with the reduction in the need for expensive lab equipment and specialized personnel, make them an attractive option for widespread and routine use.
1. Sensitivity and Specificity
Ensure the biosensor exhibits high sensitivity and specificity for the target analyte. These parameters determine the sensor's ability to detect low concentrations and differentiate between similar substances.
2. Response Time
Consider the sensor's response time, which is critical for applications requiring real-time monitoring or quick results.
3. Stability and Durability
Evaluate the biosensor's operational stability and durability under different conditions. It should maintain performance over its intended lifespan, even in challenging environments.
4. Biocompatibility
For applications involving direct contact with biological systems, the biosensor must be biocompatible to prevent adverse reactions.
5. Cost-effectiveness
Assess the overall cost-effectiveness, including initial investment, maintenance, and operational costs. An optimal supplier offers competitive pricing without compromising quality.
6. Technological Compatibility
Ensure the biosensor is compatible with existing technology and systems for seamless integration and operation.
7. Supplier Reputation and Support
Research the supplier's reputation, including customer service, technical support, and after-sales service. Opt for suppliers with a proven track record and reliable support.
Biosensors have revolutionized the healthcare industry by enabling real-time monitoring of patient health metrics. These devices are integral in diagnosing diseases early, tracking disease progression, and managing chronic conditions. By providing accurate and immediate data, healthcare professionals can make informed decisions quickly, improving patient outcomes. In the agricultural sector, biosensors play a critical role in ensuring food safety and quality. They are used to detect pathogens, pesticides, and toxins in crops and livestock, allowing for timely intervention. This technology supports sustainable farming practices by minimizing the use of harmful chemicals and reducing the risk of foodborne illnesses. The environmental monitoring field benefits from biosensors through the detection of pollutants and toxins in air, water, and soil. These devices offer a rapid and cost-effective method for assessing environmental health, facilitating the implementation of measures to protect ecosystems and public health. In the biotechnology industry, biosensors are pivotal in drug discovery and development. They allow for the screening of compounds and the monitoring of biological processes in real-time. This accelerates the pace of research and development, leading to the faster introduction of new drugs to the market. Each of these use cases underscores the versatility and impact of biosensors across different industries, highlighting their importance in driving innovation, enhancing safety, and improving quality of life.
Biosensors, as of the latest assessments, predominantly sit at Technology Readiness Level (TRL) 6 to 8, indicating that these devices have evolved from prototype testing in a laboratory environment (TRL 6) to demonstrations in relevant environments (TRL 7) and, in some cases, have reached actual system completion and qualification through tests and demonstrations in operational environments (TRL 8). This advanced TRL positioning is primarily due to substantial technical progress in material science, nanotechnology, and biotechnology, which has enabled the development of highly sensitive, selective, and durable biosensor materials. Innovations such as the integration of nanomaterials have significantly enhanced the sensitivity and specificity of biosensors, allowing for the detection of biomolecules at very low concentrations, which is crucial for early diagnosis in medical applications. Furthermore, advancements in microfabrication techniques have facilitated the miniaturization of biosensors, making them more practical for real-world applications by improving the portability and reducing the cost of these devices. Despite these advancements, challenges related to long-term stability, repeatability, and the need for calibration limit their TRL from reaching the final stage of full commercial deployment (TRL 9). However, the ongoing research and development efforts continue to address these issues, pushing the boundaries of biosensor technology further.
In the Short-Term, biosensors are poised for significant advancements in sensitivity and specificity. Immediate developments include the integration of nanomaterials, such as graphene and quantum dots, which are set to enhance the detection capabilities of these devices. This will enable the rapid identification of pathogens and biomarkers at much lower concentrations, benefiting medical diagnostics and environmental monitoring. Moving into the Mid-Term, the focus shifts towards wearable biosensors and real-time health monitoring systems. These devices will become more user-friendly, incorporating flexible, skin-like formats that can continuously track a range of physiological parameters. Advancements in wireless technology and miniaturization will facilitate seamless integration with smartphones and other personal devices, offering users instant access to health data and alerts. In the Long-Term, biosensors are expected to revolutionize personalized medicine. The development of implantable biosensors capable of long-term monitoring within the body will provide unprecedented insights into individual health trends and disease progression. These devices will likely leverage artificial intelligence to predict health issues before they manifest, enabling preventive measures and highly tailored treatment plans. This era of biosensors will usher in a new level of precision in healthcare, with a strong emphasis on prevention and personalized intervention.
